GENE ONLINE|News &
Opinion
Blog

Eli Lilly
Trials & Approvals
Long Standing Rivalry in Diabetes Market Intensifies as Eli Lilly’s Drug Outshines Novo’s in Head to Head Trial
2021-03-05
Trials & Approvals RIPK1
Lilly to Expand Foothold in the Billion-Dollar Autoimmune and Inflammatory Disease Market with this New Collaboration
2021-02-20
Deals BIO CEO & Investor Digital Conference
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
COVID-19 EUA
COVID-19: FDA Grants Emergency Use Authorization for Eli Lilly’s Antibody Combo Therapy
2021-02-10
COVID-19 COVID-19 Variant
Lilly Teams up with GSK, Vir to Fight New COVID-19 Variants Using Antibody Combo
2021-01-28
Deals Bispecific Antibody
Lilly Strikes $1.6 Billion Deal with Merus for Cancer Treating Bispecific Antibodies
2021-01-20
Trials & Approvals
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
COVID-19
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
M&A Gene Therapy
Why is Eli Lilly Seeking Prevail’s Gene Therapy Pipeline?
2020-12-17
Technology CRISPR
Eli Lilly Forays into Gene Editing with Precision BioSciences Collaboration
2020-11-21
Manufacturing Antibody Therapy
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Trials & Approvals Alopecia Areata
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
M&A SARM1
Eli Lilly Intends to Disarm Axonal Degeneration with Newest Acquisition
2020-10-17
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Trials & Approvals Rituximab
Innovent Biologics Bags Chinese Approval for Fourth Monoclonal Antibody
2020-10-12
1 2 3 4
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top